Are there ovarian carcinoma clinical trials in Pennsylvania?

Yes. We're currently tracking 28 recruiting ovarian carcinoma studies with a site in Pennsylvania, each rewritten in plain language so you can see what it's testing and who it's for.

How do I find out if I qualify for a ovarian carcinoma study in Pennsylvania?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Pennsylvania to take part?

Not necessarily. These studies have a site in Pennsylvania, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a ovarian carcinoma trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Pennsylvania

Ovarian Carcinoma clinical trials in Pennsylvania

We’re tracking 28 recruiting ovarian carcinoma studies with a site in Pennsylvania — including Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.

Recruiting studies in Pennsylvania

NCT05538091RecruitingPhase 2
Testing vismodegib plus atezolizumab for platinum-resistant ovarian cancer
This Phase 2 trial tests whether combining vismodegib with atezolizumab can slow or shrink platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer. It targets cancers that grow again within 6 months after platinum chemotherapy.
Pittsburgh, PennsylvaniaAges 18 years+
NCT04657068RecruitingPhase 1/Phase 2
Study of ART0380 for advanced solid tumors
This study tests a new drug called ART0380 for people with advanced solid tumors that have not responded to standard treatments. It may be especially helpful for those with certain DNA repair gene changes (like ATM or BRCA). The drug will be given alone or with chemotherapy (gemcitabine or irinotecan) depending on the part of the trial.
Philadelphia, PennsylvaniaAges 18 years+
NCT05334069Recruiting
Blood test study for early cancer detection in patients
This study collects blood from people with cancer and people without cancer (or with possible cancer) to test whether new blood tests can detect cancer earlier. Your blood samples help researchers evaluate how well these tests work.
Allentown, PennsylvaniaAges 40–75
NCT04585750RecruitingPhase 1/Phase 2
Studying a new drug for cancers with a specific TP53 change
This trial tests a new drug (rezatapopt) for people with advanced cancers that have a specific change in the TP53 gene, called Y220C. The drug is designed to target this change and may slow or stop cancer growth. Some participants may also receive an immunotherapy drug called pembrolizumab (Keytruda).
Philadelphia, PennsylvaniaAges 12 years+

Ovarian Carcinoma trials by city in Pennsylvania

Where these studies are running in Pennsylvania

Institutions with a site for the recruiting ovarian carcinoma studies listed above.

Abramson Cancer Center of the University of Pennsylvania
Geisinger Medical Center
Geisinger Medical Oncology-Lewisburg
Geisinger Wyoming Valley/Henry Cancer Center
Lehigh Valley Hospital - Muhlenberg
Lehigh Valley Hospital-Cedar Crest
Lehigh Valley Hospital-Hazleton
Penn State Health St. Joseph Medical Center

What taking part in a ovarian carcinoma study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Ovarian Carcinoma trials in other states

Common questions

Are there ovarian carcinoma clinical trials in Pennsylvania?: Yes. We're currently tracking 28 recruiting ovarian carcinoma studies with a site in Pennsylvania, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a ovarian carcinoma study in Pennsylvania?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Pennsylvania to take part?: Not necessarily. These studies have a site in Pennsylvania, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a ovarian carcinoma trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New ovarian carcinoma studies open in Pennsylvania regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.